Company Information
- Type:
- Company
- Country:
- Japan
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Publicly Listed
- Engagement Tier:
- Participant
- Global Compact Status:
- Active
- Participant Since
- 12 April 2012 Letter of Commitment
Financial Information
Principles and Global Goals Addressed in their most recent CoP
Next Communication on Progress (CoP) due on:
Communication On Progress
| Published On | Title | Level |
|---|---|---|
| 2020-12-25 | Daiichi Sankyo Group Value Report 2020 | Advanced |
| 2019-12-26 | Daiichi Sankyo Group Value Report 2019 | Advanced |
| 2018-12-26 | Daiichi Sankyo Group Value Report 2018 | Advanced |
| 2017-12-26 | Communication on Progress | Advanced |
| 2016-12-26 | Communication on Progress | Advanced |
| 2015-12-24 | Communication on Progress | Advanced |
| 2014-12-25 | Value Report 2014 | Advanced |
| 2013-12-26 | Value Report 2013 | Advanced |
| 2013-02-25 | Communication on Progress | Advanced |
Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.